Advances in Translational Medicine
Advances in Translational Medicine
Leticia A. Shea 1 * , Kellen J. Sorauf 2 , Ksenia S. Polson 3 , Bianca Calderon 4 , Marlee Poupard 5 , Alex Zolnir-Groshong 6
Correspondence: Lshea@regis.edu
DOI: https://doi.org/10.55976/atm.1202215117-32
Show More
[1]Meyersohn N. Dollar stores are everywhere. That’s a problem for poor Americans. CNN Business. Available from: https://www.cnn.com/2019/07/19/business/dollar-general-opposition/index.html. [Accessed November 23, 2019].
[2]Caspi CE, Pelletier JE, Harnack L, et al. Differences in healthy food supply and stocking practices between small grocery stores, gas-marts, pharmacies and dollar stores. Public Health Nutrition. 2015;19(3): 540-547. doi: 10.1017/S1368980015002724.
[3]Hale K. Dollar General bets on oasis strategy for food deserts. Forbes. Available from: https://www.forbes.com/sites/korihale/2018/12/13/dollar-general-bets-on-oasis-strategy-for-food-deserts/#76b56e124f53. [Accessed November 23, 2019].
[4]Houghtaling B, Kniola D, Misyak S. Supplemental Nutrition Assistance Program (SNAP)-Authorized Grocery, Convenience, Dollar, and Restaurant or Delivery Service Settings Are Associated With Increased Obesity Prevalence in Virginia. American Journal of Health Promotion. 2021;35(1): 127-130. doi: 10.1177/0890117120934610.
[5]Bowman S. Low socioeconomic status is associated with suboptimal intakes of nutritious foods by adults in the National Health and Nutrition Examination Survey 1999-2002. Nutrition Research. 2007;27(9): 515-523. doi: https://doi.org/10.1016/j.nutres.2007.06.010.
[6]Poor nutrition. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/chronicdisease/resources/publications/factsheets/nutrition.htm. Updated August 7, 2019. [Accessed November 23, 2019].
[7]Kopelman P. Health risks associated with overweight and obesity. Obesity reviews. 2007;8(Suppl 1): 13-17. doi: 10.1111/j.1467-789X.2007.00311.x.
[8]Pi-Sunyer X. The medical risks of obesity. Postgrad Medicine. 2009;121(6): 21-33. doi: 10.3810/pgm.2009.11.2074.
[9]U.S Food & Drug Administration (FDA). FDA issues warning letter to dollar tree stores for receiving potentially unsafe drugs. FDA News Release. Nov. 11, 2019. Available from: https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letter-dollar-tree-stores-receiving-potentially-unsafe-drugs. [Accessed on Dec. 5, 2019].
[10]Ogawa R, Echizen H. Clinically significant drug interactions with antacids: an update. Drugs. 2011;71(14): 1839-64. doi: 10.2165/11593990-000000000-00000.
[11]Michael Fay & Michael Proschan. Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Statistics Surveys. 2010;4: 1–39. doi: https://doi.org/10.1214/09-SS051.
[12]Dykewicz MS, Wallace DV, Baroody F, Bernstein J., et al. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Annals of Allergy, Asthma & Immunology. 2017; 19(6): 489-511. doi: 10.1016/j.anai.2017.08.012.
[13]Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis executive summary. Otolaryngology–Head and Neck Surgery. 2015;152(2): 197-206. doi: 10.1177/0194599814562166.
[14]Malesker MA, Callahan-Lyon P, Ireland B, Irwin RS Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. Chest. 2017;152(5): 1021-1037. doi: 10.1016/j.chest.2017.08.009.
[15]Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Practice Guidelines. American Journal of Gastroenterology. 2013;108(3):308–328. doi: 10.1038/ajg.2012.444.
[16]Paquette IM, Varma M, Ternent C, et al. The American society of colon and rectal surgeons’ clinical practice guideline for the evaluation and management of constipation. Diseases of the Colon & Rectum. 2016;59(6): 479-492. doi: 10.1097/DCR.0000000000000599.
[17]Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. American Journal of Gastroenterology. 2016;111(5): 602-622. doi: 10.1038/ajg.2016.126
[18]Chiappini E, Bortone B, Galli L, de Martino M. Guidelines for the symptomatic management of fever in children: systematic review of the literature and quality appraisal with AGREE II. BMJ Open. 2017;7(7): e015404. doi: 10.1136/bmjopen-2016-015404.
[19]Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11): 487-499. doi: 10.1212/WNL.0000000000008095.
[20]Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology. 2020;72(2): 149-162. doi: 10.1002/acr.24131.
[21]Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11): 1578-1589. doi: https://doi.org/10.1016/j.joca.2019.06.011.
[22]Fernandes L, Hagen K, Bijlsma JW, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Annals of the rheumatic diseases. 2013;72(7): 1125-1135. doi: 10.1016/j.joca.2019.06.011.
[23]Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. Journal of sleep research. 2017;26(6): 675-700. doi: 10.1111/jsr.12594.
[24]Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of clinical sleep medicine. 2008;4(5): 487–504. doi: https://doi.org/10.5664/jcsm.27286.
[25]Hatton RC, Hendeles L. Over-the-counter oral phenylephrine: A placebo for nasal congestion. The Journal of Allergy and Clinical Immunology: In Practice. 2015;3(5): 709-710. doi: 10.1016/j.jaip.2015.06.014.
[26]Horak F, Zieglmayer P, Zieglmayer R, et al. A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber. Annals of Allergy, Asthma & Immunology. 2009;102(2):116-20. doi: 10.1016/S1081-1206(10)60240-2.
[27]Benninger M, Farrar JR, Blaiss M, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Annals of Allergy, Asthma & Immunology. 2010;104(1): 13-29. doi: 10.1016/j.anai.2009.11.020.
[28]Graf P. Rhinitis medicamentosa a review of causes and treatment. Treatments in Respiratory Medicine. 2005;4(1): 21-29. doi: 10.2165/00151829-200504010-00003.
[29]Abraham O, Schleiden L, Albert SM. Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep. International Journal of Clinical Pharmacy. 2017;39(4): 808–817. doi: 10.1007/s11096-017-0467-x.
[30]2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2019;67(4): 674-694. doi: 10.1111/jgs.15767.
[31]Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Internal Medicine. 2015;175(3): 401-407. doi: 10.1001/jamainternmed.2014.7663.
[32]Meltzer EO. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunology and Allergy Clinics. 2016;36(2): 235-248. doi: 10.1016/j.iac.2015.12.002.
[33]Page RL, O'Bryant CL, Cheng D, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(6): e22-69. doi: 10.1161/CIR.0000000000000426.
[34]Mitchell RA, Rathi S, Dahiya M, et al. Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey. PLoS One. 2020;15(3): e0229070. doi: 10.1371/journal.pone.0229070.
[35]Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Archives of toxicology. 2015;89(2): 193-199. doi: 10.1007/s00204-014-1432-2.
[36]Hausner EA, Poppenga RH. Hazards associated with the use of herbal and other natural products. 3rd ed. Philadelphia: W.B. Saunders; 2013 Available from: https://www.sciencedirect.com/science/article/pii/B9781455707171000260?via%3Dihub.
[37]Emery DP, Corban JG. Camphor toxicity. Journal of Paediatrics and Child Health. 1999;35(1): 105-106. doi: 10.1046/j.1440-1754.1999.00347.x.
[38]Hachem C, Shaheen NJ. Diagnosis and Management of Functional Heartburn. American Journal of Gastroenterology. 2016;111(1): 53-62. doi: 10.1038/ajg.2015.376.
[39]Fass R, Fass SS. Psychological comorbidity and chronic heartburn: which is the chicken and which is the egg? Digestive Diseases and Sciences. 2017;62(4): 823-825. doi: 10.1007/s10620-017-4475-4.
[40]Avidan B, Sonneberg A, Giblovich H, Sontag SJ. Reflux symptoms are associated with psychiatric disease. Alimentary pharmacology & therapeutics. 2001;15(12): 1907-1912. doi: 10.1046/j.1365-2036.2001.01131.x.
[41]Ogawa R, Echizen H. Clinically significant drug interactions with antacids: an update. Drugs. 2011;71(14): 1839-64. doi: 10.2165/11593990-000000000-00000.
[42]Bowman WS, Farid A, Aronowitz P. Heartburn or heart attack? A Mimic of MI. Cleveland Clinic Journal of Medicine. 2017;84(9): 664-665. doi: 10.3949/ccjm.84a.16093.
[43]Omotosho TB, Rogers RG. Evaluation and treatment of anal incontinence, constipation, and defecatory dysfunction. Obstetrics and Gynecology Clinics. 2009;36(3): 673-697. doi: 10.1016/j.ogc.2009.08.008.
[44]Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology. 2020;158(5): 1232-1249. doi: 10.1053/j.gastro.2019.12.034.
[45]Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Medical Journal of Australia. 2018;209(2): 86-91. doi: 10.5694/mja18.00241.
[46]Noergaard M, Anderson JT, Jimenez-Solem E, et al. Long term treatment with stimulant laxatives – clinical evidence for effectiveness and safety? Scandinavian Journal of Gastroenterology. 2019;54(1): 27-34. doi: 10.1080/00365521.2018.1563806.
[47]Miller H, Panahi L, Tapia D, et al. Loperamide misuse and abuse. Journal of the American Pharmacists Association. 2017;57(2S):S45-S50. doi: 10.1016/j.japh.2016.12.079.
[48]Akel T, Bekheit S. Loperamide cardiotoxicity: “A Brief Review”. Annals of Noninvasive Electrocardiology. 2018;23(2): e12505. doi: 10.1111/anec.12505.
[49]Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of clinical sleep medicine. 2008;4(5): 487–504. doi: https://doi.org/10.5664/jcsm.27286.
Copyright © 2022 Leticia A. Shea, Kellen J. Sorauf, Ksenia S. Polson, Bianca Calderon, Marlee Poupard, Alex Zolnir-Groshong
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright licenses detail the rights for publication, distribution, and use of research. Open Access articles published by Luminescience do not require transfer of copyright, as the copyright remains with the author. In opting for open access, the author(s) should agree to publish the article under the CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license, users are free to share (copy, distribute and transmit) and remix (adapt) the contribution, including for commercial purposes, providing they attribute the contribution in the manner specified by the author or licensor.
Luminescience press is based in Hong Kong with offices in Wuhan and Xi'an, China.
E-mail: publisher@luminescience.cn
鄂公网安备 42018502004928号
网站备案号:鄂ICP备2020021880号-1
Copyright © 2021 Luminescience Press. All rights reserved.
